世界のリポソーム市場予測（～2028年）：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他

• 英文タイトル：Global Liposomes Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8880 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

リポソーム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のリポソームの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 リポソーム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 用途別セグメントは次のように区分されます。 ・真菌感染症治療、癌＆腫瘍治療、その他 世界のリポソーム市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm、Spectrum Pharmaceuticals、Shanghai New Asia 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、リポソーム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なリポソームメーカーの企業概要、2019年～2022年までのリポソームの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なリポソームメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別リポソームの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのリポソームの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのリポソーム市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびリポソームの産業チェーンを掲載しています。 ・第13、14、15章では、リポソームの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm、Spectrum Pharmaceuticals、Shanghai New Asia ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 ・用途別分析2017年-2028年：真菌感染症治療、癌＆腫瘍治療、その他 ・リポソームの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・リポソームのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・リポソームのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リポソームの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・リポソームの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Liposomes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Liposomes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Fungal Infection Therapy accounting for % of the Liposomes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liposomal Doxorubicin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Liposomes include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, and Luye Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Liposomes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Market segment by Application can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
The key market players for global Liposomes market are listed below:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposomes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposomes, with price, sales, revenue and global market share of Liposomes from 2019 to 2022.
Chapter 3, the Liposomes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposomes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Liposomes market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liposomes.
Chapter 13, 14, and 15, to describe Liposomes sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Liposomes Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liposomes Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Liposomes Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposomes Market Size & Forecast
1.4.1 Global Liposomes Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Liposomes Sales in Volume (2017-2028)
1.4.3 Global Liposomes Price (2017-2028)
1.5 Global Liposomes Production Capacity Analysis
1.5.1 Global Liposomes Total Production Capacity (2017-2028)
1.5.2 Global Liposomes Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Liposomes Market Drivers
1.6.2 Liposomes Market Restraints
1.6.3 Liposomes Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Liposomes Product and Services
2.1.4 Johnson & Johnson Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Liposomes Product and Services
2.2.4 Gilead Sciences Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pacira
2.3.1 Pacira Details
2.3.2 Pacira Major Business
2.3.3 Pacira Liposomes Product and Services
2.3.4 Pacira Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Liposomes Product and Services
2.4.4 Sun Pharmaceutical Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Liposomes Product and Services
2.5.4 Luye Pharma Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sigma-Tau Group
2.6.1 Sigma-Tau Group Details
2.6.2 Sigma-Tau Group Major Business
2.6.3 Sigma-Tau Group Liposomes Product and Services
2.6.4 Sigma-Tau Group Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fudan-Zhangjiang
2.7.1 Fudan-Zhangjiang Details
2.7.2 Fudan-Zhangjiang Major Business
2.7.3 Fudan-Zhangjiang Liposomes Product and Services
2.7.4 Fudan-Zhangjiang Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Liposomes Product and Services
2.8.4 Teva Pharmaceutical Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 CSPC
2.9.1 CSPC Details
2.9.2 CSPC Major Business
2.9.3 CSPC Liposomes Product and Services
2.9.4 CSPC Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Liposomes Product and Services
2.10.4 Novartis Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Kingond Pharm
2.11.1 Kingond Pharm Details
2.11.2 Kingond Pharm Major Business
2.11.3 Kingond Pharm Liposomes Product and Services
2.11.4 Kingond Pharm Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business
2.12.3 Spectrum Pharmaceuticals Liposomes Product and Services
2.12.4 Spectrum Pharmaceuticals Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanghai New Asia
2.13.1 Shanghai New Asia Details
2.13.2 Shanghai New Asia Major Business
2.13.3 Shanghai New Asia Liposomes Product and Services
2.13.4 Shanghai New Asia Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Liposomes Breakdown Data by Manufacturer
3.1 Global Liposomes Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Liposomes Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Liposomes
3.4 Market Concentration Rate
3.4.1 Top 3 Liposomes Manufacturer Market Share in 2021
3.4.2 Top 6 Liposomes Manufacturer Market Share in 2021
3.5 Global Liposomes Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Liposomes Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Liposomes Market Size by Region
4.1.1 Global Liposomes Sales in Volume by Region (2017-2028)
4.1.2 Global Liposomes Revenue by Region (2017-2028)
4.2 North America Liposomes Revenue (2017-2028)
4.3 Europe Liposomes Revenue (2017-2028)
4.4 Asia-Pacific Liposomes Revenue (2017-2028)
4.5 South America Liposomes Revenue (2017-2028)
4.6 Middle East and Africa Liposomes Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Liposomes Sales in Volume by Type (2017-2028)
5.2 Global Liposomes Revenue by Type (2017-2028)
5.3 Global Liposomes Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Liposomes Sales in Volume by Application (2017-2028)
6.2 Global Liposomes Revenue by Application (2017-2028)
6.3 Global Liposomes Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Liposomes Sales by Type (2017-2028)
7.2 North America Liposomes Sales by Application (2017-2028)
7.3 North America Liposomes Market Size by Country
7.3.1 North America Liposomes Sales in Volume by Country (2017-2028)
7.3.2 North America Liposomes Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Liposomes Sales by Type (2017-2028)
8.2 Europe Liposomes Sales by Application (2017-2028)
8.3 Europe Liposomes Market Size by Country
8.3.1 Europe Liposomes Sales in Volume by Country (2017-2028)
8.3.2 Europe Liposomes Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Liposomes Sales by Type (2017-2028)
9.2 Asia-Pacific Liposomes Sales by Application (2017-2028)
9.3 Asia-Pacific Liposomes Market Size by Region
9.3.1 Asia-Pacific Liposomes Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Liposomes Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Liposomes Sales by Type (2017-2028)
10.2 South America Liposomes Sales by Application (2017-2028)
10.3 South America Liposomes Market Size by Country
10.3.1 South America Liposomes Sales in Volume by Country (2017-2028)
10.3.2 South America Liposomes Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Liposomes Sales by Type (2017-2028)
11.2 Middle East & Africa Liposomes Sales by Application (2017-2028)
11.3 Middle East & Africa Liposomes Market Size by Country
11.3.1 Middle East & Africa Liposomes Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Liposomes Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Liposomes and Key Manufacturers
12.2 Manufacturing Costs Percentage of Liposomes
12.3 Liposomes Production Process
12.4 Liposomes Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Liposomes Typical Distributors
13.3 Liposomes Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---